《盈利預喜》貝康醫療-B(02170.HK)料上半年毛利按年增長最多20.5%
貝康醫療-B(02170.HK)發盈喜,預期上半年的總收益將介乎7,940萬至8,780萬元人民幣(下同),較去年同期的6,860萬元增加15.7%至28%,收益增加乃主要由於PGT-A試劑盒及超低溫儲存設備的銷售額所致。
此外,公司預期上半年的毛利將介乎3,020萬至3,640萬元,較去年同期的3,020萬元增加不高於20.5%,毛利增加乃主要由於收益增加所致。預期集團上半年的整體毛利率將介乎39%至41.5%,與2022年相應同期比較維持穩定。
公司已於今年6月21日完成收購BMX Holdco,預期BMX Holdco上半年的總收益將介乎4,360萬至4,460萬元,按年增加19.7%至22.5%,收益增加乃主要由於若干亞洲國家的銷售額增加所致;毛利料將介乎2,490萬至2,590萬元,按年增加10.6%至15.1%,毛利增加乃由於收益增加所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.